title: siRNA Targeting the 2Apro Genomic Region Prevents Enterovirus 71 Replication In Vitro.
abstract: Enterovirus 71 (EV71) is the most important etiological agent of hand, foot, and mouth disease (HFMD) in young children, which is associated with severe neurological complications and has caused significant mortalities in recent HFMD outbreaks in Asia. However, there is no effective antiviral therapy against EV71. In this study, RNA interference (RNAi) was used as an antiviral strategy to inhibit EV71 replication. Three small interfering RNAs (siRNAs) targeting the 2Apro region of the EV71 genome were designed and synthesized. All the siRNAs were transfected individually into rhabdomyosarcoma (RD) cells, which were then infected with strain EV71-2006-52-9. The cytopathic effects (CPEs) in the infected RD cells, cell viability, viral titer, and viral RNA and protein expression were examined to evaluate the specific viral inhibition by the siRNAs. The results of cytopathogenicity and MTT tests indicated that the RD cells transfected with the three siRNAs showed slight CPEs and significantly high viability. The 50% tissue culture infective dose (TCID50) values demonstrated that the viral titer of the groups treated with three siRNAs were lower than those of the control groups. qRT-PCR and western blotting revealed that the levels of viral RNA and protein in the RD cells treated with the three siRNAs were lower than those in the controls. When RD cells transfected with siRNAs were also infected with strain EV71-2008-43-16, the expression of the VP1 protein was significantly inhibited. The levels of interferon α (IFN-α) and IFN-β did not differ significantly in any group. These results suggest that siRNAs targeting the 2Apro region of the EV71 genome exerted antiviral effects in vitro.
authors.affiliation: Department of Clinical Laboratory, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
authors.forename: Haibing
authors.initials: H
authors.lastname: Liu
authors.affiliation: Department of Immunology, Institute of Laboratory Medicine, Jiangsu University, Zhenjiang, China.
authors.forename: Yanyan
authors.initials: Y
authors.lastname: Qin
authors.affiliation: Department of Immunology, Institute of Laboratory Medicine, Jiangsu University, Zhenjiang, China.
authors.forename: Zhenzhen
authors.initials: Z
authors.lastname: Kong
authors.affiliation: Department of Immunology, Institute of Laboratory Medicine, Jiangsu University, Zhenjiang, China.
authors.forename: Qixiang
authors.initials: Q
authors.lastname: Shao
authors.affiliation: Department of Immunology, Institute of Laboratory Medicine, Jiangsu University, Zhenjiang, China.
authors.forename: Zhaoliang
authors.initials: Z
authors.lastname: Su
authors.affiliation: Department of Clinical Laboratory, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
authors.forename: Shengjun
authors.initials: S
authors.lastname: Wang
authors.affiliation: Department of Clinical Laboratory, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
authors.forename: Jianguo
authors.initials: J
authors.lastname: Chen
mesh_terms: D001681:Biological Assay; D045744:Cell Line, Tumor; D002470:Cell Survival; D003588:Cytopathogenic Effect, Viral; D019610:Cytoprotection; D029821:Enterovirus A, Human / Q000235:genetics* / Q000502:physiology*; D016679:Genome, Viral; D006801:Humans; D007372:Interferons / Q000378:metabolism; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000378:metabolism*; D012367:RNA, Viral / Q000235:genetics; D014162:Transfection; D014764:Viral Proteins / Q000378:metabolism; D014779:Virus Replication / Q000235:genetics*
chemical_list: D034741:RNA, Small Interfering; D012367:RNA, Viral; D014764:Viral Proteins; D007372:Interferons